Global Information Inc. would like to present a new market research report, "Systemic Nasal Sprays: Products, Players, Markets and Forecasts" by Greystone Research Associates.
Systemic Nasal Sprays: Products, Players, Markets and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.
As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies for chronic conditions such as diabetes, arthritis, and hormone replacement therapy, drug developers are showing increased interest in routes of administration that are patient-friendly and cost-effective.
Drug developers and researchers are discovering that the accessibility and vascular structure of the nose make it an attractive route for delivering both small molecule drugs and biologics, systemically as well as across the blood-brain barrier to the CNS. Nasal delivery offers the potential for faster onset of action and less frequent dosing relative to oral drugs.
Intranasal administration is well positioned to evolve into a significant role in the future of pharmaceutical development and commercialization. Intranasal delivery will grow at the expense of the predominant drug delivery methods (oral and parenteral), which cannot be readily optimized for the delivery and dosing of a significant portion of biologically derived drug substances.